| 药品英文名 |
药品中文名称 |
效构类别 |
| tasidotin hydrochloride |
|
抗肿瘤药, antineoplastic |
| tecalcet hydrochloride |
|
拟钙剂, calcimimetic |
| telavancin hydrochloride |
|
抗生素>糖肽类, antibiotic |
| tenivastatin calcium |
|
心血管系统>降血脂药>HMG CoA 还原酶抑制药>他汀类, antihyperlipidaemic |
| tetraxetan |
|
radical designation for a chelating agent |
| TOLEVAMER POTASSIUM SODIUM |
|
Treatment of Clostridium difficle associated diarrhea |
| TOLEVAMER SODIUM |
|
Treatment of Clostridium difficle associated diarrhea |
| valategrast hydrochloride |
|
消炎镇痛药, non-steroidal anti-inflammatory |
| valopicitabine dihydrochloride |
|
抗病毒药>核苷及核苷酸类>逆转录酶抑制药>, antiviral |
| valtorcitabine dihydrochloride |
盐酸伐托他滨 |
抗病毒药>核苷及核苷酸类>逆转录酶抑制药>, antiviral |
| varenicline tartrate |
|
烟碱样乙酰胆碱受体激动药, nicotinic acetylcholine receptor agonist |
| varespladib sodium |
伐瑞拉迪钠 |
胞质磷脂酶A2抑制药, secretory phospholipase A2 inhibitor |
| vestipitant mesylate |
甲磺酸维替吡坦 |
消化系统>镇吐药>神经激肽NK1受体拮抗药，neurokinin NK1 receptor antagonist |
| vicriviroc maleate |
|
抗病毒药，antiviral |
| YTTRIUM Y 90 EPRATUZUMAB TETRAXETAN |
|
放射性免疫治疗药物 |
| YTTRIUM Y 90 LABETUZUMAB TETRAXETAN |
|
放射性免疫治疗药物 |
| zosuquidar trihydrochloride |
|
抗肿瘤药, antineoplastic, multidrug resistant inhibitor |
| zoniporide mesylate |
|
Na+/H+反转抑制剂, Na+/H+ antiport inhibitor |
| YTTRIUM Y 90 LABETUZUMAB |
|
放射性免疫治疗药物 |
| YTTRIUM Y 90 EPRATUZUMAB |
|
放射性免疫治疗药物 |
| Epetirimod esylate |
|
抗肿瘤药，抗病毒药 |
| ISCOTRIZINOL |
|
皮肤>紫外线防护药>三嗪衍生物类，Sunscreen |
| LUCATUMUMAB |
|
抗肿瘤药>单克隆抗体类, antineoplastic |
| milnacipran hydrochloride |
盐酸米那普仑 |
神经系统>抗抑郁药>其它 |
| MITUMPROTIMUT-T |
|
Treatment of follicular B cell non-Hodgkins lymphoma |
